Berwick, Daniel C <br/><br/>
Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of β-catenin signaling.  [electronic resource] 

 -  Molecular neurodegeneration  01 2017 
 - 9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1750-1326 
<br/><br/><label>Standard No.: </label>10.1186/s13024-017-0153-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Dopaminergic Neurons--metabolism<br/>Immunoprecipitation--methods<br/>Leucine-Rich Repeat Serine-Threonine Protein Kinase-2--genetics<br/>Mice, Knockout<br/>Mutation--genetics<br/>Parkinson Disease--genetics<br/>Protein Serine-Threonine Kinases--genetics<br/>Wnt Signaling Pathway--genetics<br/>beta Catenin--genetics